Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sultana M. Shefin"'
Autor:
Mohammad Saifuddin, Ajit K. Paul, Sultana M. Shefin, Md. Jahangir Alam, Shahjada Selim, Sunjida Islam, Tanjina Hossain, Sadiqa Tuqan, Nusrat Sultana, Marufa Mustari, Ramen C. Basak, Kazi A. Aftab, Indrajit Prasad, Mohammad R. Uddin, Shoma Sharker, Md. Abu Jar Gaffar, Mohammad M. Rahman, Mohammad A. Hannan, Afsar Ahammed, ABM Kamrul-Hasan
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 5, Pp 500-509 (2024)
Background: Empagliflozin is a relatively newer glucose-lowering drug (GLD) with many extra-glycemic benefits. To date, no study has evaluated the efficacy and safety of empagliflozin in Bangladeshi patients with type 2 diabetes mellitus (T2DM). Obje
Externí odkaz:
https://doaj.org/article/70e8fbdd22054143beaad373bede1e9c
Autor:
Saifuddin, Mohammad1 (AUTHOR), Paul, Ajit K.2 (AUTHOR), Shefin, Sultana M.3 (AUTHOR), Alam, Md. Jahangir4 (AUTHOR), Selim, Shahjada5 (AUTHOR), Islam, Sunjida6 (AUTHOR), Hossain, Tanjina7 (AUTHOR), Tuqan, Sadiqa8 (AUTHOR), Sultana, Nusrat5 (AUTHOR), Mustari, Marufa5 (AUTHOR), Basak, Ramen C.9 (AUTHOR), Aftab, Kazi A.10 (AUTHOR), Prasad, Indrajit1 (AUTHOR), Uddin, Mohammad R.11 (AUTHOR), Sharker, Shoma12 (AUTHOR), Gaffar, Md. Abu Jar13 (AUTHOR), Rahman, Mohammad M.14 (AUTHOR), Hannan, Mohammad A.15 (AUTHOR), Ahammed, Afsar16 (AUTHOR), Kamrul-Hasan, ABM17 (AUTHOR) rangassmc@gmail.com
Publikováno v:
Indian Journal of Endocrinology & Metabolism. Sep/Oct2024, Vol. 28 Issue 5, p500-509. 10p.